Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

Guidelines for the reanalysis of clinical data

Home Our project areas Genomic diagnostics Guidelines for the reanalysis of clinical…

Summary

When a patient has a genomic test, they are provided with a clinical report that outlines if a change (variant) in a gene has been found in their genetic code, which may explain their condition or disease – potentially providing a diagnosis.

In some patients this is clear cut – a disease-causing variant is found which can then be used to test other family members. In other cases, no variant is detected, or a variant of unknown significance is discovered. The unknown significance may be due to the lack of available comparison data (for example how often we see that change across a population). It may also be because further work is needed on how the variant changes how cells function.

Finally, over time some clinical features of a disease become more obvious, helping to link the gene variant to the patient’s disease.

For all these reasons, there is a need to periodically reanalyse patients’ genomic data to allow for a more accurate interpretation of a genetic change.

This project will investigate how Australian clinical services and laboratories are approaching this problem. The project will then establish a set of guidelines that can be applied across Australia’s state and territory health system.

The guidelines will include who will fund the reanalysis and how the genomic data needs to be safely and securely stored. These guidelines will ensure high quality genomic healthcare can be provided to all Australians.

Project Lead

Professor Julie McGaughran

Genetic Health Queensland

Project Coordinator

Dr Michael Quinn

Contact michael.quinn3@health.qld.gov.au


More projects

Shariant

RCPA QAP genomic interpretive module

PanelApp Australia

Connect with us

(03) 9936 6345
info@australiangenomics.org.au
50 Flemington Road, Parkville
Victoria 3052 Australia

In the spirit of reconciliation Australian Genomics acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.

To stay informed about our work, sign up to our newsletter

Subscribe

Quicklinks

  • Home
  • What we do
  • What we offer
  • Tools & resources
  • Our publications
  • Our project areas
  • Research we’re supporting
  • Our team

Privacy

  • We follow the Australian Privacy Principles
  • General privacy policy
  • Website privacy policies
  • Terms & conditions

Website by Blueboat.